Pfizer (PFE) Net Margin Growth (3y) (2012 - 2026)
Pfizer (PFE) Net Margin Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn | -204.00 |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn | 666.00 |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn | 3,167.00 |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn | -43,067.00 |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn | 37.00 |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn | 388.00 |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn | -15,026.00 |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn | -6,857.00 |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn | -1,745.00 |
| 10 | Sanofi | 55.07 Bn | 47.69 Bn | 10.79 Bn | -1,144.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 28, 2026 | 11.00 |
| Mar 29, 2026 | -12.00 |
| Jun 29, 2025 | 98.00 |
| Sep 29, 2024 | 41.00 |
| Jun 30, 2024 | 141.00 |
| Mar 31, 2024 | -4.00 |
| Jul 2, 2023 | -911.00 |
| Apr 2, 2023 | -871.00 |
| Oct 3, 2021 | -51.00 |
| Apr 4, 2021 | 1.00 |
| Jun 28, 2020 | 904.00 |
| Dec 31, 2018 | 63,374.00 |
| Apr 1, 2018 | -5.00 |
| Dec 31, 2017 | 13.00 |
| Jul 3, 2016 | -8,030.00 |
| Dec 31, 2015 | -2,929.00 |
| Mar 29, 2015 | -48.00 |
| Dec 31, 2014 | -490.00 |
| Sep 28, 2014 | -860.00 |
| Mar 30, 2014 | -520.00 |